Developing breakthrough vaccine technologies
Our promise
BunyaVax exploits proprietary technology to develop safe and efficacious vaccines against neglected diseases of animals and humans
Combining efficacy
with safety
© Juha Huiskonen
The technology
BunyaVax has developed proprietary technologies to attenuate bunyaviruses and uses these technologies to develop live attenuated vaccines that optimally combine efficacy with safety. The technologies are also being used to develop diagnostic assays of unmatched specificity and sensitivity.
​
BunyaVax prioritizes viral pathogens that affect animal and human health in developing countries and is collaborating with the Coalition for Epidemic Preparedness Innovations (CEPI) and leading human and animal health pharma.
​
Protecting animal and human health
Vaccines continue to be the most effective tool to control epizootics and epidemics, protecting animal and public health.
Creating sustained immunity in animals and humans
© Juha Huiskonen
Stay In Touch.
